If the subject's underlying cancer is a solid tumor, current status must be stable disease, partial response, or complete response to therapy; if the subject's underlying disease is a hematologic malignancy, current status must be in remission; [clinicaltrials_resource:6f5765f1430a0aa2cba41c7ed5d079b9]

If the subject's underlying cancer is a solid tumor, current status must be stable disease, partial response, or complete response to therapy; if the subject's underlying disease is a hematologic malignancy, current status must be in remission; [clinicaltrials_resource:6f5765f1430a0aa2cba41c7ed5d079b9]